Garton & Associates Financial Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102
Closed -$13.9K 716
2025
Q4
$13.9K Buy
+102
New +$14.7K 0.01% 748

Other funds holding XYL

Garton & Associates Financial Advisors's XYL Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Xylem (XYL) in Q1 2026, closing a stake of 102 shares — an estimated $13.9K sold.

Garton & Associates Financial Advisors first reported a position in XYL in Q4 2025 and held it in 1 quarter. The position peaked at $13.9K in Q4 2025. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 102 Xylem shares in Q1 2026, an estimated $13.9K.
  • Garton & Associates Financial Advisors first reported a position in Xylem in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Xylem position peaked at $13.9K in Q4 2025.
  • 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.